Cargando…

Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients

BACKGROUND: Red blood cell (RBC) transfusion is a common treatment for hospitalized patients. However, the effects of RBC transfusion on microvascular function remain controversial. METHODS: In a medical ICU in a tertiary teaching hospital, we prospectively included anemic patients requiring RBC tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariri, Geoffroy, Bourcier, Simon, Marjanovic, Zora, Joffre, Jérémie, Lemarié, Jérémie, Lavillegrand, Jean-Rémi, Charue, Dominique, Duflot, Thomas, Bigé, Naïke, Baudel, Jean-Luc, Maury, Eric, Mohty, Mohamad, Guidet, Bertrand, Bellien, Jeremy, Blanc-Brude, Olivier, Ait-Oufella, Hafid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717366/
https://www.ncbi.nlm.nih.gov/pubmed/31470888
http://dx.doi.org/10.1186/s13054-019-2572-9
_version_ 1783447543073472512
author Hariri, Geoffroy
Bourcier, Simon
Marjanovic, Zora
Joffre, Jérémie
Lemarié, Jérémie
Lavillegrand, Jean-Rémi
Charue, Dominique
Duflot, Thomas
Bigé, Naïke
Baudel, Jean-Luc
Maury, Eric
Mohty, Mohamad
Guidet, Bertrand
Bellien, Jeremy
Blanc-Brude, Olivier
Ait-Oufella, Hafid
author_facet Hariri, Geoffroy
Bourcier, Simon
Marjanovic, Zora
Joffre, Jérémie
Lemarié, Jérémie
Lavillegrand, Jean-Rémi
Charue, Dominique
Duflot, Thomas
Bigé, Naïke
Baudel, Jean-Luc
Maury, Eric
Mohty, Mohamad
Guidet, Bertrand
Bellien, Jeremy
Blanc-Brude, Olivier
Ait-Oufella, Hafid
author_sort Hariri, Geoffroy
collection PubMed
description BACKGROUND: Red blood cell (RBC) transfusion is a common treatment for hospitalized patients. However, the effects of RBC transfusion on microvascular function remain controversial. METHODS: In a medical ICU in a tertiary teaching hospital, we prospectively included anemic patients requiring RBC transfusion. Skin microvascular reactivity was measured before and 30 min after RBC transfusion. Plasma was collected to analyze intravascular hemolysis and draw the lipidomic and cytokine profiles. RESULTS: In a cohort of 59 patients, the median age was 66 [55–81] years and SAPS II was 38 [24–48]. After RBC transfusion, endothelium-dependent microvascular reactivity improved in 35 (59%) patients, but worsened in 24 others (41%). Comparing clinical and biological markers revealed that baseline blood leucokyte counts distinguished improving from worsening patients (10.3 [5.7; 19.7] vs. 4.6 [2.1; 7.3] × 10(9)/L; p = 0.001) and correlated with variations of microvascular reactivity (r = 0.36, p = 0.005). Blood platelet count was also higher in improving patients (200 [97; 280] vs 160 [40; 199] × 10(3)/mL, p = 0.03) but did not correlate with variations of microvascular reactivity. We observed no intravascular hemolysis (HbCO, heme, bilirubin, LDH), but recorded a significant increase in RBC microparticle levels specific to improving patients after transfusion (292 [108; 531] vs. 53 [34; 99] MP/μL; p = 0.03). The improvement in microvascular dilation was positively correlated with RBC microparticle levels (R = 0.83, p < 0.001) and conversion of arachidonic acid into vasodilating eicosanoids. CONCLUSIONS: Patients displaying an improved microvascular reactivity after RBC transfusion had high blood leukocyte counts, increased RBC microparticle formation, and enhanced metabolism of arachidonic acid into vasodilating lipids. Our data suggested a contribution of recipient leukocytes to the vascular impact of RBC transfusion. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13054-019-2572-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6717366
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67173662019-09-06 Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients Hariri, Geoffroy Bourcier, Simon Marjanovic, Zora Joffre, Jérémie Lemarié, Jérémie Lavillegrand, Jean-Rémi Charue, Dominique Duflot, Thomas Bigé, Naïke Baudel, Jean-Luc Maury, Eric Mohty, Mohamad Guidet, Bertrand Bellien, Jeremy Blanc-Brude, Olivier Ait-Oufella, Hafid Crit Care Research BACKGROUND: Red blood cell (RBC) transfusion is a common treatment for hospitalized patients. However, the effects of RBC transfusion on microvascular function remain controversial. METHODS: In a medical ICU in a tertiary teaching hospital, we prospectively included anemic patients requiring RBC transfusion. Skin microvascular reactivity was measured before and 30 min after RBC transfusion. Plasma was collected to analyze intravascular hemolysis and draw the lipidomic and cytokine profiles. RESULTS: In a cohort of 59 patients, the median age was 66 [55–81] years and SAPS II was 38 [24–48]. After RBC transfusion, endothelium-dependent microvascular reactivity improved in 35 (59%) patients, but worsened in 24 others (41%). Comparing clinical and biological markers revealed that baseline blood leucokyte counts distinguished improving from worsening patients (10.3 [5.7; 19.7] vs. 4.6 [2.1; 7.3] × 10(9)/L; p = 0.001) and correlated with variations of microvascular reactivity (r = 0.36, p = 0.005). Blood platelet count was also higher in improving patients (200 [97; 280] vs 160 [40; 199] × 10(3)/mL, p = 0.03) but did not correlate with variations of microvascular reactivity. We observed no intravascular hemolysis (HbCO, heme, bilirubin, LDH), but recorded a significant increase in RBC microparticle levels specific to improving patients after transfusion (292 [108; 531] vs. 53 [34; 99] MP/μL; p = 0.03). The improvement in microvascular dilation was positively correlated with RBC microparticle levels (R = 0.83, p < 0.001) and conversion of arachidonic acid into vasodilating eicosanoids. CONCLUSIONS: Patients displaying an improved microvascular reactivity after RBC transfusion had high blood leukocyte counts, increased RBC microparticle formation, and enhanced metabolism of arachidonic acid into vasodilating lipids. Our data suggested a contribution of recipient leukocytes to the vascular impact of RBC transfusion. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13054-019-2572-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-30 /pmc/articles/PMC6717366/ /pubmed/31470888 http://dx.doi.org/10.1186/s13054-019-2572-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hariri, Geoffroy
Bourcier, Simon
Marjanovic, Zora
Joffre, Jérémie
Lemarié, Jérémie
Lavillegrand, Jean-Rémi
Charue, Dominique
Duflot, Thomas
Bigé, Naïke
Baudel, Jean-Luc
Maury, Eric
Mohty, Mohamad
Guidet, Bertrand
Bellien, Jeremy
Blanc-Brude, Olivier
Ait-Oufella, Hafid
Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients
title Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients
title_full Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients
title_fullStr Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients
title_full_unstemmed Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients
title_short Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients
title_sort exploring the microvascular impact of red blood cell transfusion in intensive care unit patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717366/
https://www.ncbi.nlm.nih.gov/pubmed/31470888
http://dx.doi.org/10.1186/s13054-019-2572-9
work_keys_str_mv AT haririgeoffroy exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT bourciersimon exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT marjanoviczora exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT joffrejeremie exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT lemariejeremie exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT lavillegrandjeanremi exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT charuedominique exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT duflotthomas exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT bigenaike exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT baudeljeanluc exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT mauryeric exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT mohtymohamad exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT guidetbertrand exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT bellienjeremy exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT blancbrudeolivier exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients
AT aitoufellahafid exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients